Synthetic Fusion Protein CAR Technology to Redirect T Cell Antigen Specificity to Promote Organ Transplant Tolerance

tolerance kidney transplantation/nephrology immunosuppression/immune modulation immunosuppressant immunobiology immune regulation graft survival gene therapy fusion proteins and monoclonal antibodies: T cell specific editorial/personal viewpoint basic (laboratory) research/science

Domaines

Médecine humaine et pathologie

Fichier sous embargo

Date de visibilité indéterminée

Sylvie Le Bihan : Connectez-vous pour contacter le contributeur

https://inserm.hal.science/inserm-02155966

Soumis le : vendredi 14 juin 2019-09:25:19

Dernière modification le : lundi 4 mars 2024-13:36:06

Dates et versions

inserm-02155966 , version 1 (14-06-2019)

Identifiants

HAL Id : inserm-02155966 , version 1
DOI : 10.1111/ajt.14211

Citer

Sophie Brouard, N. Mooney. Synthetic Fusion Protein CAR Technology to Redirect T Cell Antigen Specificity to Promote Organ Transplant Tolerance. American Journal of Transplantation, 2017, 17 (4), pp.854-855. ⟨10.1111/ajt.14211⟩. ⟨inserm-02155966⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UNIV-PARIS7 UNIV-NANTES USPC SITE-ALSACE CRTI ANR NANTES-UNIVERSITE CR2TI UFR-MEDECINE-NANTES

30 Consultations

1 Téléchargements